Poehling Capital Management’s ENvue Medical Inc FEED Stock Holding History

Poehling Capital Management’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-833	Closed	-$17K	–	173
2026 Q1	$17K	Buy	+833	New	+$21.6K	﹤0.01%	153

Other funds holding FEED

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Poehling Capital Management's FEED Position: Q2 2026 in Review

Poehling Capital Management sold out of ENvue Medical Inc (FEED) in Q2 2026, closing a stake of 833 shares — an estimated $17K sold.

Poehling Capital Management first reported a position in FEED in Q1 2026 and held it in 1 quarter. The position peaked at $17K in Q1 2026. 12 funds tracked by Wall St. Rank hold FEED as of Q2 2026.

Poehling Capital Management reported no remaining ENvue Medical Inc position as of Q2 2026 after selling out during the quarter.
Poehling Capital Management sold 833 ENvue Medical Inc shares in Q2 2026, an estimated $17K.
Poehling Capital Management first reported a position in ENvue Medical Inc in Q1 2026 and held it in 1 quarter.
Poehling Capital Management's ENvue Medical Inc position peaked at $17K in Q1 2026.
12 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q2 2026.

Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.